Lesaka details prelim FY25 results and restatement
Lesaka Technologies, Inc. furnished preliminary financial results for its fourth quarter and year ended June 30, 2025, while also addressing a significant accounting restatement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lesaka Technologies, Inc. furnished preliminary financial results for its fourth quarter and year ended June 30, 2025, while also addressing a significant accounting restatement. The company’s audit committee, after consulting management and KPMG Inc., concluded that the unaudited condensed consolidated financial statements in its Form 10-Qs for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025 should be restated and no longer relied upon. The restatement stems from a re-evaluation of how certain revenue and related costs were classified between agent and principal.
Lesaka currently expects the restatement to increase reported revenue, offset by higher cost of goods sold and IT processing, servicing and support, with no impact on operating income (loss), net loss, loss per share, net cash flows or liquidity. The preliminary results and related press release are subject to completion of the restatement and the financial close process, have not been audited or reviewed, and may change, potentially materially. The company highlights risks around the timing and scope of the restatement, possible effects on internal control over financial reporting and disclosure controls, and potential legal or regulatory actions related to the restatement.
Positive
- None.
Negative
- Three quarters of financial statements to be restated and no longer relied upon, due to re-evaluation of agent versus principal revenue classification.
- Disclosure of risks around internal control effectiveness and potential legal or regulatory action tied to the restatement introduces added uncertainty.
Insights
Lesaka faces an accounting restatement that raises control and disclosure risks.
Lesaka Technologies is restating three recent quarters because of a re-evaluation of whether certain revenue should be reported on an agent versus principal basis. The affected unaudited condensed consolidated financial statements in the Form 10-Qs for quarters ended September 30, 2024, December 31, 2024, and March 31, 2025 are no longer to be relied upon, which is a material development for users of those reports.
The company currently expects the restatement to increase reported revenue with a corresponding increase in cost of goods sold and IT processing, servicing and support, and no impact on operating income (loss), net loss, loss per share, net cash flows or liquidity. However, the preliminary fourth quarter and full-year results have not been audited, reviewed, or compiled and are expressly subject to change as the restatement and financial close are completed.
Management flags several risks, including uncertainties around the effectiveness of internal control over financial reporting and disclosure controls, the possibility that additional agreements may require similar revenue restatements, and potential legal or regulatory action related to the restatement. Future SEC filings completing the restatement and any related control conclusions will be important for understanding the longer-term implications.
8-K Event Classification
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lesaka Technologies, Inc. (LSAK) disclose in this 8-K?
Which Lesaka (LSAK) financial periods will be restated?
Why is Lesaka restating prior quarterly results?
Will the Lesaka restatement affect profit or cash flow metrics?
Are Lesaka’s preliminary Q4 and FY 2025 results final?
AI-generated analysis. How Rhea-AI works. Not financial advice.